» Articles » PMID: 29972648

1α,25-dihydroxyvitamin D-eluting Nanofibrous Dressings Induce Endogenous Antimicrobial Peptide Expression

Overview
Specialty Biotechnology
Date 2018 Jul 5
PMID 29972648
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The aim of this study was to develop a nanofiber-based dressing capable of local sustained delivery of 1α,25-dihydroxyvitamin D (1,25(OH)D) and augmenting human CAMP induction.

Materials & Methods: Nanofibrous wound dressings containing 1,25(OH)D were successfully prepared by electrospinning, which were examined in vitro, in vivo and ex vivo.

Results: 1,25(OH)D was successfully loaded into nanofibers with encapsulation efficiency larger than 90%. 1,25(OH)D showed a sustained release from nanofibers over 4 weeks. Treatment of U937 and HaCaT cells with 1,25(OH)D-loaded poly(ϵ-caprolactone) nanofibers significantly induced hCAP18/LL37 expression in monocytes and keratinocytes, skin wounds of humanized transgenic mice and artificial wounds of human skin explants.

Conclusion: 1,25(OH)D containing nanofibrous dressings could enhance innate immunity by inducing antimicrobial peptide production.

Citing Articles

Electrospun fiber-based immune engineering in regenerative medicine.

Xu Y, Saiding Q, Zhou X, Wang J, Cui W, Chen X Smart Med. 2024; 3(1):e20230034.

PMID: 39188511 PMC: 11235953. DOI: 10.1002/SMMD.20230034.


Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis.

Nakamura Y, Kulkarni N, Takahashi T, Alimohamadi H, Dokoshi T, Liu E J Clin Invest. 2024; 134(5).

PMID: 38194294 PMC: 10904043. DOI: 10.1172/JCI172578.


Induction of Endogenous Antimicrobial Peptides to Prevent or Treat Oral Infection and Inflammation.

Morio K, Sternowski R, Brogden K Antibiotics (Basel). 2023; 12(2).

PMID: 36830272 PMC: 9952314. DOI: 10.3390/antibiotics12020361.


Electrospun Nanofibers for Wound Management.

John J, McCarthy A, Karan A, Xie J ChemNanoMat. 2022; 8(7).

PMID: 35990019 PMC: 9384963. DOI: 10.1002/cnma.202100349.


Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection.

Xu B, Li F, Zhang W, Su Y, Tang L, Li P iScience. 2022; 25(6):104447.

PMID: 35707727 PMC: 9189130. DOI: 10.1016/j.isci.2022.104447.


References
1.
Anderson D . Prevention of surgical site infection: beyond SCIP. AORN J. 2014; 99(2):315-9. PMC: 3947534. DOI: 10.1016/j.aorn.2013.11.007. View

2.
Pendleton J, Gorman S, Gilmore B . Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013; 11(3):297-308. DOI: 10.1586/eri.13.12. View

3.
Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T . An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest. 2003; 111(11):1665-72. PMC: 156109. DOI: 10.1172/JCI17545. View

4.
Saiman L, Tabibi S, Starner T, San Gabriel P, Winokur P, Jia H . Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother. 2001; 45(10):2838-44. PMC: 90740. DOI: 10.1128/AAC.45.10.2838-2844.2001. View

5.
Yosef I, Manor M, Qimron U . Counteracting selection for antibiotic-resistant bacteria. Bacteriophage. 2016; 6(1):e1096996. PMC: 4836461. DOI: 10.1080/21597081.2015.1096996. View